Study Description: Brief Summary: A double-blind, randomized, placebo-controlled, single-center, 12-month phase 2 study designed to assess the safety and efficacy of VM202 as a replacement for opioid analgesics in opioid-tolerant subjects with painful diabetic peripheral neuropathy (DPN).

Read the details.

Related Posts

Learning to Apply Mindfulness to Pain (LAMP)

Published On:

Comparison of Physical Versus Visual Distraction in the Reduction of Pain During Local Anesthesia

Published On:

Expanded Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

Published On: